<DOC>
	<DOCNO>NCT02172586</DOCNO>
	<brief_summary>Study assess efficacy telmisartan 40-80 mg daily compare losartan 50-100 mg daily hypertensive patient evaluate change baseline diastolic blood pressure ( DBP ) last 6 hour 24-hour dose interval , end 12 week period monotherapy treatment ( ABPM - ambulatory blood pressure measurement ) . Secondary objective : Changes baseline BP end monotherapy period treatment end study , evaluate sphygmomanometric blood pressure measurement ABPM Safety : Incidence adverse event ( AE 's ) ; withdrawal due adverse event ; laboratory parameter</brief_summary>
	<brief_title>Telmisartan With Without Hydrochlorothiazide ( HCTZ ) Compared With Losartan With Without HCTZ Mild Moderate Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Age ≥ 18 year Mildtomoderate essential hypertension define mean diastolic blood pressure ( DBP ) ≥ 95 mmHg &lt; 110 mmHg systolic blood pressure ( SBP ) &lt; 180 mmHg measure manual cuff sphygmomanometer end washout period Written inform consent Nursing , pregnancy childbearing potential woman , postmenopausal woman enrol last menstruation &gt; 1 year prior start washout phase surgically sterile Secondary hypertension Malignant hypertension ( retinal haemorrhage , exudate papillary oedema ) Clinically significant sodium depletion define serum sodium level &lt; 130 mEq/L and/or clinically significant hyperkaliemia define serum potassium level &gt; 5.5 mEq/L clinically significant hypokaliemia define serum potassium level &lt; 3.0 mEq/L Atrial fibrillation frequent ventricular ectopic beat arrhythmias , investigator opinion could compromise patient 's participation trial Congestive heart failure ( CHF ) ( NYHA ( New York Heart Association ) functional class CHF IIIIV ) Angina pectoris myocardial infarction Cardiac surgery within past 3 month prior start washout period Stroke within past 6 month prior start washout period Renal insufficiency define creatininaemia &gt; 2mg/dl Bilateral renal artery stenosis , renal artery stenosis solitary kidney , post renal transplant , presence one functioning kidney Liver insufficiency , define bilirubinaemia &gt; 2mg/dl AST ( aspartate aminotransferase ) ALT ( alanineaminotransferase ) &gt; twice upper normal range Clinically significant metabolic endocrine disease Autoimmune disease Previous history angioedema Body mass index &gt; 30kg/m2 Arm circumference &gt; 32 cm Any condition may likely compromise patient participation trial ( alcohol drug abuse , disability illness , etc . ) Concomitant therapy antihypertensive drug non permit protocol , corticosteroid drug know affect blood pressure Concomitant use lithium cholestyramine colestipol resin ( potential drug interaction HCTZ ) Investigational drug treatment within past 30 day enrolment concurrent participation trial Sensitivity , significant adverse reaction contraindication study drug ( telmisartan , losartan , HCTZ ) Predictable lack patient cooperation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>